These results indicate that EphA2 acts as tumor suppressor and RNF5 depletion suppresses the xenograft tumor growth of HER2-negative breast cancer cells through increased level of EphA2 and unbalance of EphA2 phosphorylation. The gene discussed is EPHA2; the disease is breast cancer.